Selvita sets final IPO price

Biotechnology firm Selvita has set the final price of shares in its initial public offering at PLN 10.3 apiece, the company said in a statement on Wednesday. It brings the expected IPO value to PLN 27.3 million. The offer will include only newly issued shares. The stocks will be allocated to individual (12 percent) and institutional (88 percent) investors. Selvita plans to spend the issue proceeds on innovative projects, especially in the cancer treatment sphere. The company hopes to debut on the main market of the Warsaw Stock Exchange before the end of 2014.